<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?origin publisher?><?properties no_embargo?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Transgenic Res</journal-id><journal-title>Transgenic Research</journal-title><issn pub-type="ppub">0962-8819</issn><issn pub-type="epub">1573-9368</issn><publisher><publisher-name>Springer Netherlands</publisher-name><publisher-loc>Dordrecht</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17972156</article-id><article-id pub-id-type="publisher-id">9153</article-id><article-id pub-id-type="doi">10.1007/s11248-007-9153-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Mast cell-specific Cre/loxP-mediated recombination in&#x000a0;vivo</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Scholten</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hartmann</surname><given-names>Karin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gerbaulet</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Krieg</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>M&#x000fc;ller</surname><given-names>Werner</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Testa</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Roers</surname><given-names>Axel</given-names></name><address><phone>+49-221-4783196</phone><fax>+49-221-4785949</fax><email>axel.roers@uni-koeln.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Dermatology, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany </aff><aff id="Aff2"><label>2</label>Faculty of Life Sciences, University of Manchester, Simon Building, Brunswick Street, Manchester, M13 9PL UK </aff><aff id="Aff3"><label>3</label>European Institute of Oncology, Via Adamello, 16, Milan, 20139 Italy </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>10</month><year>2007</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2008</year></pub-date><volume>17</volume><issue>2</issue><fpage>307</fpage><lpage>315</lpage><history><date date-type="received"><day>8</day><month>8</month><year>2007</year></date><date date-type="accepted"><day>9</day><month>10</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9; Springer Science+Business Media B.V. 2007</copyright-statement></permissions><abstract><p>Mast cells are important effectors of type I allergy but also essential regulators of innate and adaptive immune responses. The aim of this study was to develop a Cre recombinase-expressing mouse line that allows mast cell-specific inactivation of genes in&#x000a0;vivo. Following a BAC transgenic approach, Cre was expressed under the control of the <italic>mast cell protease (Mcpt) 5</italic> promoter. <italic>Mcpt5-Cre</italic> transgenic mice were crossed to the ROSA26-EYFP Cre excision reporter strain. Efficient Cre-mediated recombination was observed in mast cells from the peritoneal cavity and the skin while only minimal reporter gene expression was detected outside the mast cell compartment. Our results show that the <italic>Mcpt5</italic> promoter can drive Cre expression in a mast cell-specific fashion. We expect that our <italic>Mcpt5-Cre</italic> mice will be a useful tool for the investigation of mast cell biology.</p></abstract><kwd-group><title>Keywords</title><kwd>Mast cells</kwd><kwd>Conditional gene targeting</kwd><kwd>Cre/<italic>loxP</italic>-mediated recombination</kwd><kwd>Cre transgenic mice</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media B.V. 2008</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Mast cells are central effector cells in type I allergy (Kawakami and Galli <xref ref-type="bibr" rid="CR10">2002</xref>; Metcalfe et&#x000a0;al. <xref ref-type="bibr" rid="CR17">1997</xref>), but have recently been shown to be important initiators and effectors also of innate immunity as well as modulators of adaptive immune responses (Galli et&#x000a0;al. <xref ref-type="bibr" rid="CR5">2005a</xref>, <xref ref-type="bibr" rid="CR6">b</xref>; Marshall and Jawdat <xref ref-type="bibr" rid="CR16">2004</xref>). Many reports demonstrated a role of mast cells in host defence against pathogens (Dawicki and Marshall <xref ref-type="bibr" rid="CR3">2007</xref>; Echtenacher et&#x000a0;al. <xref ref-type="bibr" rid="CR4">1996</xref>; Malaviya et&#x000a0;al. <xref ref-type="bibr" rid="CR14">1996</xref>) and implicated a function of these cells in wound healing, tissue remodeling and transplant tolerance (Lu et&#x000a0;al. <xref ref-type="bibr" rid="CR13">2006</xref>; Trautmann et&#x000a0;al. <xref ref-type="bibr" rid="CR27">2000</xref>; Weller et&#x000a0;al. <xref ref-type="bibr" rid="CR31">2006</xref>). A pathogenic role of mast cells was discussed in rheumatoid arthritis, systemic sclerosis, multiple sclerosis and atherosclerosis (Bachelet et&#x000a0;al. <xref ref-type="bibr" rid="CR1">2006</xref>; Irani et&#x000a0;al. <xref ref-type="bibr" rid="CR9">1992</xref>; Lee et&#x000a0;al. <xref ref-type="bibr" rid="CR12">2002</xref>; Secor et&#x000a0;al. <xref ref-type="bibr" rid="CR22">2000</xref>; Sun et&#x000a0;al. <xref ref-type="bibr" rid="CR26">2007</xref>).</p><p>Investigation of mast cell biology was severely hampered by the scarcity of these cells in tissues. Experimental systems that have widely been used are in&#x000a0;vitro analysis of mast cell lines or mast cells differentiated in&#x000a0;vitro from bone marrow (BMMC). In&#x000a0;vivo analysis of the function of genes in mast cells until today relied on the reconstitution of mast cell-deficient rodents with mast cells derived from bone marrow or hematopoietic cells of gene-deficient animals or from gene-deficient embryonic stem cells (Kitamura et&#x000a0;al. <xref ref-type="bibr" rid="CR11">1978</xref>; Nakano et&#x000a0;al. <xref ref-type="bibr" rid="CR18">1985</xref>; Tsai et&#x000a0;al. <xref ref-type="bibr" rid="CR29">2002</xref>, <xref ref-type="bibr" rid="CR30">2000)</xref>. These systems yielded valuable information, but suffer important limitations. In the mouse lines <italic>kit</italic><sup><italic>W/W-v</italic></sup> and <italic>kit</italic><sup><italic>W-sh/W-sh</italic></sup>, which are commonly used for reconstitution experiments, spontaneous mutations of the <italic>kit</italic> gene coding region or its regulatory elements result in reduced activity of the kit receptor that controls development and survival of mast cells (Galli et&#x000a0;al. <xref ref-type="bibr" rid="CR6">2005b</xref>; Grimbaldeston et&#x000a0;al. <xref ref-type="bibr" rid="CR7">2005</xref>). In addition to mast cell-deficiency, <italic>kit</italic><sup><italic>W/W-v</italic></sup>animals are characterized by sterility, anemia, absence of melanocytes and interstitial cells of Cajal, a high incidence of dermatitis, papillomas of the forestomach, gastric ulcers and dilation of the duodenum (Galli et&#x000a0;al. <xref ref-type="bibr" rid="CR6">2005b</xref>). <italic>kit</italic><sup><italic>W-sh</italic></sup> animals, which lately are being used instead of <italic>kit</italic><sup><italic>W/W-v</italic></sup> mice, seem to feature a more narrow defect with deficiency for mast cells, melanocytes, and interstitial cells of Cajal (Grimbaldeston et&#x000a0;al. <xref ref-type="bibr" rid="CR7">2005</xref>). The transfer of <italic>in&#x000a0;vitro</italic> cultivated mast cells into mast cell-deficient animals by intradermal, intraperitoneal or intravenous injections can result in mast cell numbers, which, dependent on the route of cell transfer and the anatomical site, can approach normal mast cell density, but often remain considerably lower with significant variability (Grimbaldeston et&#x000a0;al. <xref ref-type="bibr" rid="CR7">2005</xref>; Tsai et&#x000a0;al. <xref ref-type="bibr" rid="CR28">2005</xref>).</p><p>The Cre/<italic>loxP</italic> recombination system represents a powerful tool that allows for conditional, e.g. cell type-specific, inactivation of genes in the mouse (Rajewsky et&#x000a0;al. <xref ref-type="bibr" rid="CR20">1996</xref>). Since the first description of in&#x000a0;vivo mutagenesis using the Cre/<italic>loxP</italic> system (Gu et&#x000a0;al. <xref ref-type="bibr" rid="CR8">1994</xref>), an impressive number of floxed mouse lines has been generated. Herein, we report the first <italic>Cre</italic> transgenic line allowing mast cell-specific gene inactivation in&#x000a0;vivo.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Material and methods</title><sec id="Sec3"><title>Construction of the transgene and generation of transgenic mice</title><p>The construct was based on a bacterial artificial chromosome (BAC) encompassing the entire <italic>Mcpt5</italic> gene. The BAC clone RP23-284A14 from the mouse BAC library RPCI-23 (Osoegawa et&#x000a0;al. <xref ref-type="bibr" rid="CR19">2000</xref>) was obtained from RZPD (Deutsches Ressourcenzentrum f&#x000fc;r Genomforschung GmbH, Berlin, Germany). All modifications were done by homologous recombination in <italic>E. coli</italic> (Zhang et&#x000a0;al. <xref ref-type="bibr" rid="CR32">1998</xref>) and sequences of all oligonucleotides used for construction by homologous recombination are listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Neighbouring genes contained in the BAC were excluded by replacing several kb of DNA at both ends of the insert by resistance genes (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). In a next step, a modified i<italic>Cre</italic> (<underline>i</underline>mproved Cre, Shimshek et&#x000a0;al. <xref ref-type="bibr" rid="CR23">2002</xref>) gene cassette (Testa et&#x000a0;al. unpublished) was inserted into the <italic>Mcpt5</italic> gene. The <italic>Cre</italic> cassette was first assembled with a <italic>loxm2</italic>-flanked neomycin-resistance cassette (<italic>neo</italic>) and flanked by homology regions (HR) for recombination into the <italic>Mcpt5</italic> gene. This was done by subcloning the <italic>Cre</italic> cDNA into a minimal vector consisting of the origin of replication and a chloramphenicol resistance gene amplified from pACYC184 (New England Biolabs, Frankfurt, Germany). The primers used for the amplification contain the HRs for both subcloning of <italic>Cre</italic> and insertion into the <italic>Mcpt5</italic> gene (see Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). In a next step, the neomycin cassette was inserted 3&#x02032; of <italic>Cre</italic> and 5&#x02032; of the <italic>Mcpt5</italic> HR. The HR-<italic>Cre-Neo</italic>-HR cassette was released from the minimal vector by <italic>Not</italic>I digestion and recombined into the BAC replacing the coding part of exon 1 of the <italic>Mcpt5</italic> gene followed by Cre-mediated deletion of <italic>neo</italic>. The construct was purified for pronucleus injection as described by Sparwasser et&#x000a0;al. (<xref ref-type="bibr" rid="CR24">2004</xref>) with modifications. Briefly, the construct was separated from the BAC backbone by <italic>Not</italic>I digest and purified by gel electrophoresis and electroelution. Pronucleus injection was done by R. Naumann, MPI of Molecular Cell Biology and Genetics, Dresden, Germany. Genotyping of <italic>Mcpt5-Cre</italic> transgenic mice was performed by PCR (primers: Mcpt5-CreFor 5&#x02032;ACAGTGGTATTCCCGGGGAGTGT, Mcpt5-CreRev 5&#x02032; GTCAGTGCGTTCAAAGGCCA). Founder mice were bred to the ROSA26-EYFP reporter line (Srinivas et&#x000a0;al. <xref ref-type="bibr" rid="CR25">2001</xref>) and five to 15&#x000a0;week old mice were analyzed for reporter gene expression. Animals were housed under SPF conditions and all experiments were done according to institutional guidelines. <table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Primers used for transgene construction by homologous recombination</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="2"><inline-graphic xlink:href="11248_2007_9153_Figa_HTML.gif" id="N0x1c74d10N0x2f6dd00"/></td></tr></tbody></table><table-wrap-foot><p>Oligonucleotides used for transgene construction by homologous recombination. The respective 50&#x000a0;bp homology regions (HR) were included into the primers used for the amplification of selection markers or the minimal vector</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Strategy of transgene construction. The BAC RP23-284A14 was shortened by replacing 51.3&#x000a0;kb of insert DNA at the T7 end of the vector backbone and 42.4&#x000a0;kb at the SP6 end by an ampicillin (Amp) and zeocin (Zeo) resistance cassette, respectively, resulting in a residual insert length of 129&#x000a0;kb. A <italic>Not</italic>I restriction site was inserted along with each of the resistance genes. The coding part of the first exon of <italic>Mcpt5</italic> was replaced by a cassette comprising the <italic>Cre</italic> cassette and a <italic>loxm2</italic>-flanked neomycin resistance cassette (Neo) by homologous recombination and subsequent deletion of <italic>neo</italic> by Cre-mediated deletion in <italic>E. coli</italic>. (<italic>Not</italic>I, N, <italic>EcoR</italic>I, I, arrows represent open reading frames, shaded boxes represent untranslated regions)</p></caption><graphic position="anchor" xlink:href="11248_2007_9153_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec4"><title>Flow cytometric analysis</title><p>Total splenocyte suspensions were separated into lymphocyte and non-lymphocyte fractions by magnetic cell sorting (MACS, Miltenyi Biotec, Bergisch Gladbach, Germany) using anti-CD3-Biotin (clone 145-2C11, BD Pharmingen), anti-Biotin MicroBeads, anti-CD19 MicroBeads and LS MACS columns (Miltenyi Biotec). Skin cell suspensions were prepared from shaved abdominal skin plus one ear pinna by mincing followed by an incubation with 2&#x000a0;mg/ml collagenase IV (Worthington Biochem. Corporation, Lakewood, NJ, USA) at 37&#x000b0;C. Cells in peritoneal lavage as well as single cell suspensions from skin and spleen were stained with phycoerythrin (PE)-conjugated anti-CD3 (clone 145-2C11), anti-CD19 (clone 1D3); anti-CD11c (clone HL3), anti-CD45 (clone 30-F11) and anti-Siglec-F (clone E50-2440) (all from BD Pharmingen) or anti-Fc&#x003b5;RI&#x003b1;-PE (clone MAR-1), allophycocyanin (APC)-conjugated anti-CD117 (clone 2B8) and anti-CD49b (clone D&#x000d7;5), F4/80-Biotin (clone BM8) and streptavidin-PE (all from eBiosciences, SanDiego, CA) or anti-Gr-1-PE (clone RB6-8C5) (Miltenyi Biotech). The cells were analyzed on a FACSCalibur (BD Biosciences).</p></sec></sec><sec id="Sec5"><title>Results</title><sec id="Sec6"><title>Transgene construction and screening of transgenic mice for Cre expression</title><p>In order to drive Cre expression in mast cells, we used a BAC clone containing the entire <italic>Mcpt5</italic> gene along with abundant upstream and downstream flanking DNA (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Neighboring genes were excluded by shortening the BAC on both ends to avoid possible effects of altered gene dosage in the transgenic mice. In a next step, the coding part of the first exon of <italic>Mcpt5</italic> was replaced by the <italic>Cre</italic> cassette (see Methods and Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). The construct was released from the BAC backbone by <italic>Not</italic>I digest (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) and injected into the pronuclei of C57BL/6 oocytes. Six <italic>Mcpt5-Cre</italic> transgenic founder animals were obtained and mated to a ROSA26 reporter line (Srinivas et&#x000a0;al. <xref ref-type="bibr" rid="CR25">2001</xref>) which expresses enhanced yellow fluorescent protein (EYFP) under the control of the ubiquitous <italic>ROSA26</italic> promoter following Cre-mediated deletion of a <italic>loxP</italic>-flanked stop element. <italic>Mcpt5-Cre</italic><italic>ROSA26</italic>-<italic>EYFP</italic> double transgenic animals were analyzed for EYFP expression in peritoneal and skin mast cells by FACS as described below (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Reporter gene expression was detected in mast cells from three of the six founder lines. One of these lines showed EYFP expression in only 80% of peritoneal mast cells and was not investigated further. Close to 100% of peritoneal mast cells were EYFP positive in two lines, which, because of autosomal inheritance of the transgene in one line and X-linked inheritance in the other, were called &#x0201c;A-Mcpt5-Cre&#x0201d; and &#x0201c;X-Mcpt5-Cre&#x0201d;, respectively. <fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Efficiency of Cre-mediated reporter gene activation in mast cells. EYFP expression is demonstrated in cells from peritoneal lavage fluid and single cell suspensions of skin of <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice. Peritoneal mast cells were stained for CD117 and Fc&#x003b5;RI&#x003b1; (n&#x000a0;=&#x000a0;7) and skin mast cells for CD117 and CD45 (n&#x000a0;=&#x000a0;4). Mast cell populations were gated and their EYFP fluorescence displayed in histogram plots. The black graph represents <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice, the shaded graph represents the <italic>Cre-</italic>negative but <italic>ROSA26-EYFP</italic>-positive control (littermates in most instances)</p></caption><graphic position="anchor" xlink:href="11248_2007_9153_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec7"><title>Efficient and mast cell-specific Cre-mediated recombination in the lines A-Mcpt5-Cre and X-Mcpt5-Cre</title><p>Highly efficient Cre-mediated activation of reporter gene expression was uniformly observed in peritoneal CD117<sup>+</sup>Fc&#x003b5;RI&#x003b1;<sup>+ </sup>mast cells of seven <italic>A-Mcpt5-Cre ROSA26-EYFP</italic> double transgenic animals (98.7&#x02013;99.6%, on average 99.1%, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). In skin cell suspensions mast cells were detected in extremely low numbers, on average 0.32%. (Skin mast cells were defined as CD117<sup>+</sup>CD45<sup>+ </sup>cells. A staining of Fc&#x003b5;RI&#x003b1; on skin mast cells was not reliable in our hands, likely due to loss of epitopes after enzymatic tissue digestion). In the five animals for which this mast cell population was investigated, the majority of the few CD117<sup>+</sup>CD45<sup>+ </sup>cells gated was EYFP positive (43/47, 54/64, 32/39, 23/27 and 77/88 gated events, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Given that the mast cell gate will inevitably collect also some non-mast cells upon analysis of high total cell numbers (40,000 events), the percentage of skin mast cells expressing EYFP is probably close to 100%. A similar efficiency of Cre-mediated activation of the reporter gene was observed in three male X-Mcpt5-Cre mice (not shown) whereas the two female animals analyzed showed EYFP fluorescence in only 61% and 32% of peritoneal mast cells consistent with random X-chromosome inactivation (not shown).</p><p>In both lines, Cre-mediated activation of EYFP expression was specific for mast cells. In seven A-Mcpt5-Cre and three male X-Mcpt5-Cre animals we detected no or only minimal numbers (i.e. below 1%) of EYFP positive cells (below 3% in one A-Mcpt5-Cre animal) in hematopoietic populations other than mast cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) or in non-hematopoietic cells of the skin cell suspensions (primarily keratinocytes and fibroblasts, not shown). As a control, we used mice with germline deletion of the stop element of the ROSA26-EYFP Cre excision reporter demonstrating that all non-mast cell populations analysed for reporter expression in <italic>Mcpt5-Cre</italic> mice can, in principle, express EYFP (not shown). In contrast to the seven A-Mcpt5-Cre mice (described above) showing mast cell-specific Cre-mediated recombination, one A-Mcpt5-Cre mouse displayed non-specific reporter gene expression in 15&#x02013;25% of all cell types analyzed including non-hematopoietic cells of the skin (not shown). This finding likely reflects accidental early activity of the transgenic <italic>Mcpt5</italic> promoter. <fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Absence of EYFP reporter gene expression in hematopoietic cells other than mast cells. EYFP expression was analyzed in hematopoietic cells from peritoneal lavage and spleen cell suspensions of <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice. In order to enrich granulocytes, splenocytes were separated into a lymphocyte and non-lymphocyte fraction by MACS. Basophils were double stained for CD49b and Fc&#x003b5;RI&#x003b1;. Macrophages, dendritic cells, neutrophils, eosinophils, B cells and T cells were stained for F4/80, CD11c, Gr-1, Siglec-F, CD19 and CD3&#x003b5;, respectively. The respective populations were gated and displayed in histogram plots. The black graph represents <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic mice, the shaded graph represents the <italic>Cre-</italic>negative but <italic>ROSA26-EYFP</italic>-positive control (littermates in most instances)</p></caption><graphic position="anchor" xlink:href="11248_2007_9153_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec8"><title>Absence of significant Cre-mediated genotoxicity in mast cells of Mcpt5-Cre animals</title><p>In order to exclude a reduced proliferative potential of mast cells in <italic>Mcpt5-Cre</italic> transgenic mice due to Cre-mediated genotoxic effects, we compared the percentage of mast cells in peritoneal lavage and the proliferation of peritoneal mast cells from <italic>Mcpt5-Cre ROSA26-EYFP</italic> double transgenic or wild-type mice in&#x000a0;vitro. Cell suspensions obtained by peritoneal lavage contained similar numbers of mast cells in wild-type and double transgenic mice (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). Total peritoneal lavage cells were cultured in the presence of stem cell factor. After 23&#x000a0;days, these cultures contained 98% mast cells as judged by expression of CD117 and Fc&#x0025b;RI&#x003b1; (not shown). By this time, absolute cell numbers had increased more than 200-fold in both cultures (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). Importantly, the mast cells grown from the <italic>Mcpt5-Cre ROSA26-EYFP</italic> positive mouse uniformly expressed EYFP (not shown) ruling out an overgrowth of the culture by a (hypothetical) minor population of mast cells, which do not express Cre. These results show that <italic>Mcpt5-Cre</italic> positive mast cells are not growth retarded and therefore do not seem to be significantly affected by Cre-mediated genotoxicity. <fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Numbers and proliferative potential of peritoneal mast cells in <italic>Mcpt5-Cre</italic> transgenic mice. (<bold>a</bold>) Mast cells were quantified in peritoneal lavage fluid from control (n&#x000a0;=&#x000a0;9) and <italic>Mcpt5-Cre</italic> (7 A-Mcpt5-Cre and 3 male X-Mcpt5-Cre) mice. Mast cells were detected as CD117<sup>+</sup>Fc&#x003b5;RI&#x003b1;<sup>+</sup> cells by FACS. (<bold>b</bold>) Total cells from peritoneal lavage fluid from one control and one <italic>A-Mcpt5Cre ROSA26-EYFP</italic> double transgenic mouse were incubated in complete Opti-MEM supplemented with 4% supernatant from CHO transfectants secreting murine SCF (Malbec et&#x000a0;al. <xref ref-type="bibr" rid="CR15">2007</xref>). The CHO transfectants were generated by S. Lyman, Immunex, Seattle and were kindly provided by P. Dubreuil. Cell numbers were quantified at each passage every 3&#x02013;4&#x000a0;days by counting trypan blue-excluding cells</p></caption><graphic position="anchor" xlink:href="11248_2007_9153_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec9"><title>Discussion</title><p>Here, we describe a novel Cre transgenic mouse allowing mast cell-specific knock out of genes in&#x000a0;vivo. We employed BAC transgene technology to express a <italic>Cre</italic> cassette under the control of the <italic>Mcpt5</italic> promoter. To our knowledge, this is the first report of mast cell-specific Cre-mediated recombination in the mouse.</p><p>To date, important insights into functions of mast cells have been gained by reconstitution of mast cell-deficient mice with mast cells differentiated in&#x000a0;vitro from gene deficient bone marrow or embryonic and hematopoietic stem cells (Galli et&#x000a0;al. <xref ref-type="bibr" rid="CR6">2005b</xref>; Grimbaldeston et&#x000a0;al. <xref ref-type="bibr" rid="CR7">2005</xref>; Kitamura et&#x000a0;al. <xref ref-type="bibr" rid="CR11">1978</xref>; Tsai et&#x000a0;al. <xref ref-type="bibr" rid="CR28">2005</xref>). While this model yielded important information, inherent technical problems limit experimentation and interpretation of data in this system (Tsai et&#x000a0;al. <xref ref-type="bibr" rid="CR28">2005</xref>). We expect that mast cell-specific knock out of genes using our new <italic>Cre</italic> transgenic line will greatly facilitate investigation of mast cell biology.</p><p>The two <italic>Cre</italic> transgenic lines demonstrate that the <italic>Mcpt5</italic>-promoter allows efficient and cell type-specific expression of a <italic>Cre</italic> transgene inserted into the first exon. One animal of the line A-Mcpt5-Cre (characterized by <underline>a</underline>utosomal transgene inheritance) showed non-specific Cre-mediated recombination in non-mast cells while seven animals of this line did not. This finding likely reflects accidental early activity of the transgenic <italic>Mcpt5</italic> promoter, e.g. in one stem cell during the embryonic four cell stage. Future analysis will define the frequency of such events more precisely. In females of the X-Mcpt5-Cre line (<underline>X</underline>-chromosomal inheritance), Cre-mediated recombination occurred in only about half of the mast cells due to inactivation of the transgene-carrying X-chromosome. Incomplete inactivation of particular genes may be advantageous if the attenuation of a severe phenotype is desired.</p><p>Cre recombinase has been shown to mediate genotoxicity in some <italic>Cre</italic> transgenic or <italic>Cre</italic> knock in mouse strains resulting in a reduced proliferative potential or even death of Cre expressing cells (Schmidt-Supprian and Rajewsky <xref ref-type="bibr" rid="CR21">2007</xref>). In <italic>Mcpt5-Cre</italic> mice, however, we found no difference in mast cell numbers or proliferation of mast cells <italic>ex vivo</italic> in response to stem cell factor indicating that Cre-mediated genome damage is not a prominent feature of these mice.</p><p>We are currently refining our system further to achieve also inducible mast cell-specific gene inactivation in adult mice. In addition, we are breeding the new lines to iDTR mice (Buch et&#x000a0;al. <xref ref-type="bibr" rid="CR2">2005</xref>) aiming at diphtheria toxin-inducible ablation of the mast cell lineage in adult animals.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors wish to thank Tobias Haering and Carmen Berns for excellent technical assistance. We thank Dr. P. Dubreuil for providing SCF producing CHO transfectants.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bachelet</surname><given-names>I</given-names></name><name><surname>Levi-Schaffer</surname><given-names>F</given-names></name><name><surname>Mekori</surname><given-names>YA</given-names></name></person-group><article-title>Mast cells: not only in allergy</article-title><source>Immunol Allergy Clin North Am</source><year>2006</year><volume>26</volume><fpage>407</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.iac.2006.05.007</pub-id></citation><citation citation-type="display-unstructured">Bachelet I, Levi-Schaffer F, Mekori YA (2006) Mast cells: not only in allergy. Immunol Allergy Clin North Am 26:407&#x02013;425 <pub-id pub-id-type="pmid">16931286</pub-id></citation></ref><ref id="CR2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buch</surname><given-names>T</given-names></name><name><surname>Heppner</surname><given-names>FL</given-names></name><name><surname>Tertilt</surname><given-names>C</given-names></name><name><surname>Heinen</surname><given-names>TJ</given-names></name><name><surname>Kremer</surname><given-names>M</given-names></name><name><surname>Wunderlich</surname><given-names>FT</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Waisman</surname><given-names>A</given-names></name></person-group><article-title>A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration</article-title><source>Nat methods</source><year>2005</year><volume>2</volume><fpage>419</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1038/nmeth762</pub-id></citation><citation citation-type="display-unstructured">Buch T, Heppner FL, Tertilt C, Heinen TJ, Kremer M, Wunderlich FT, Jung S, Waisman A (2005) A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat methods 2:419&#x02013;426 <pub-id pub-id-type="pmid">15908920</pub-id></citation></ref><ref id="CR3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dawicki</surname><given-names>W</given-names></name><name><surname>Marshall</surname><given-names>JS</given-names></name></person-group><article-title>New and emerging roles for mast cells in host defense</article-title><source>Curr Opin Immunol</source><year>2007</year><volume>19</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2006.11.006</pub-id></citation><citation citation-type="display-unstructured">Dawicki W, Marshall JS (2007) New and emerging roles for mast cells in host defense. Curr Opin Immunol 19:31&#x02013;38 <pub-id pub-id-type="pmid">17126541</pub-id></citation></ref><ref id="CR4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Echtenacher</surname><given-names>B</given-names></name><name><surname>Mannel</surname><given-names>DN</given-names></name><name><surname>Hultner</surname><given-names>L</given-names></name></person-group><article-title>Critical protective role of mast cells in a model of acute septic peritonitis</article-title><source>Nature</source><year>1996</year><volume>381</volume><fpage>75</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1038/381075a0</pub-id></citation><citation citation-type="display-unstructured">Echtenacher B, Mannel DN, Hultner L (1996) Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75&#x02013;77 <pub-id pub-id-type="pmid">8609992</pub-id></citation></ref><ref id="CR5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galli</surname><given-names>SJ</given-names></name><name><surname>Kalesnikoff</surname><given-names>J</given-names></name><name><surname>Grimbaldeston</surname><given-names>MA</given-names></name><name><surname>Piliponsky</surname><given-names>AM</given-names></name><name><surname>Williams</surname><given-names>CM</given-names></name><name><surname>Tsai</surname><given-names>M</given-names></name></person-group><article-title>Mast cells as &#x0201c;tunable&#x0201d; effector and immunoregulatory cells: recent advances</article-title><source>Annu Rev Immunol</source><year>2005</year><volume>23</volume><fpage>749</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.21.120601.141025</pub-id></citation><citation citation-type="display-unstructured">Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M (2005a) Mast cells as &#x0201c;tunable&#x0201d; effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749&#x02013;786 <pub-id pub-id-type="pmid">15771585</pub-id></citation></ref><ref id="CR6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galli</surname><given-names>SJ</given-names></name><name><surname>Nakae</surname><given-names>S</given-names></name><name><surname>Tsai</surname><given-names>M</given-names></name></person-group><article-title>Mast cells in the development of adaptive immune responses</article-title><source>Nat Immunol</source><year>2005</year><volume>6</volume><fpage>135</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1038/ni1158</pub-id></citation><citation citation-type="display-unstructured">Galli SJ, Nakae S, Tsai M (2005b) Mast cells in the development of adaptive immune responses. Nat Immunol 6:135&#x02013;142 <pub-id pub-id-type="pmid">15662442</pub-id></citation></ref><ref id="CR7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grimbaldeston</surname><given-names>MA</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Piliponsky</surname><given-names>AM</given-names></name><name><surname>Tsai</surname><given-names>M</given-names></name><name><surname>Tam</surname><given-names>SY</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name></person-group><article-title>Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in&#x000a0;vivo</article-title><source>Am J Pathol</source><year>2005</year><volume>167</volume><fpage>835</fpage><lpage>848</lpage></citation><citation citation-type="display-unstructured">Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ (2005) Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in&#x000a0;vivo. Am J Pathol 167:835&#x02013;848 <pub-id pub-id-type="pmid">16127161</pub-id></citation></ref><ref id="CR8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Marth</surname><given-names>JD</given-names></name><name><surname>Orban</surname><given-names>PC</given-names></name><name><surname>Mossmann</surname><given-names>H</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><article-title>Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting</article-title><source>Science</source><year>1994</year><volume>265</volume><fpage>103</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1126/science.8016642</pub-id></citation><citation citation-type="display-unstructured">Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K (1994) Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265:103&#x02013;106 <pub-id pub-id-type="pmid">8016642</pub-id></citation></ref><ref id="CR9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Irani</surname><given-names>AM</given-names></name><name><surname>Gruber</surname><given-names>BL</given-names></name><name><surname>Kaufman</surname><given-names>LD</given-names></name><name><surname>Kahaleh</surname><given-names>MB</given-names></name><name><surname>Schwartz</surname><given-names>LB</given-names></name></person-group><article-title>Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation</article-title><source>Arthritis Rheum</source><year>1992</year><volume>35</volume><fpage>933</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1002/art.1780350813</pub-id></citation><citation citation-type="display-unstructured">Irani AM, Gruber BL, Kaufman LD, Kahaleh MB, Schwartz LB (1992) Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation. Arthritis Rheum 35:933&#x02013;939 <pub-id pub-id-type="pmid">1642658</pub-id></citation></ref><ref id="CR10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>T</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name></person-group><article-title>Regulation of mast-cell and basophil function and survival by IgE</article-title><source>Nat Rev Immunol</source><year>2002</year><volume>2</volume><fpage>773</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1038/nri914</pub-id></citation><citation citation-type="display-unstructured">Kawakami T, Galli SJ (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2:773&#x02013;786 <pub-id pub-id-type="pmid">12360215</pub-id></citation></ref><ref id="CR11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>Y</given-names></name><name><surname>Go</surname><given-names>S</given-names></name><name><surname>Hatanaka</surname><given-names>K</given-names></name></person-group><article-title>Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation</article-title><source>Blood</source><year>1978</year><volume>52</volume><fpage>447</fpage><lpage>452</lpage></citation><citation citation-type="display-unstructured">Kitamura Y, Go S, Hatanaka K (1978) Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52:447&#x02013;452 <pub-id pub-id-type="pmid">352443</pub-id></citation></ref><ref id="CR12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DM</given-names></name><name><surname>Friend</surname><given-names>DS</given-names></name><name><surname>Gurish</surname><given-names>MF</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name></person-group><article-title>Mast cells: a cellular link between autoantibodies and inflammatory arthritis</article-title><source>Science</source><year>2002</year><volume>297</volume><fpage>1689</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.1126/science.1073176</pub-id></citation><citation citation-type="display-unstructured">Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB (2002) Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297:1689&#x02013;1692 <pub-id pub-id-type="pmid">12215644</pub-id></citation></ref><ref id="CR13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>LF</given-names></name><name><surname>Lind</surname><given-names>EF</given-names></name><name><surname>Gondek</surname><given-names>DC</given-names></name><name><surname>Bennett</surname><given-names>KA</given-names></name><name><surname>Gleeson</surname><given-names>MW</given-names></name><name><surname>Pino-Lagos</surname><given-names>K</given-names></name><name><surname>Scott</surname><given-names>ZA</given-names></name><name><surname>Coyle</surname><given-names>AJ</given-names></name><name><surname>Reed</surname><given-names>JL</given-names></name><name><surname>Snick</surname><given-names>J</given-names></name><name><surname>Strom</surname><given-names>TB</given-names></name><name><surname>Zheng</surname><given-names>XX</given-names></name><name><surname>Noelle</surname><given-names>RJ</given-names></name></person-group><article-title>Mast cells are essential intermediaries in regulatory T-cell tolerance</article-title><source>Nature</source><year>2006</year><volume>442</volume><fpage>997</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1038/nature05010</pub-id></citation><citation citation-type="display-unstructured">Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, Scott ZA, Coyle AJ, Reed JL, Van Snick J, Strom TB, Zheng XX, Noelle RJ (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442:997&#x02013;1002 <pub-id pub-id-type="pmid">16921386</pub-id></citation></ref><ref id="CR14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malaviya</surname><given-names>R</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Ross</surname><given-names>E</given-names></name><name><surname>Abraham</surname><given-names>SN</given-names></name></person-group><article-title>Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha</article-title><source>Nature</source><year>1996</year><volume>381</volume><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/381077a0</pub-id></citation><citation citation-type="display-unstructured">Malaviya R, Ikeda T, Ross E, Abraham SN (1996) Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381:77&#x02013;80 <pub-id pub-id-type="pmid">8609993</pub-id></citation></ref><ref id="CR15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malbec</surname><given-names>O</given-names></name><name><surname>Roget</surname><given-names>K</given-names></name><name><surname>Schiffer</surname><given-names>C</given-names></name><name><surname>Iannascoli</surname><given-names>B</given-names></name><name><surname>Dumas</surname><given-names>AR</given-names></name><name><surname>Arock</surname><given-names>M</given-names></name><name><surname>Da&#x000eb;ron</surname><given-names>M</given-names></name></person-group><article-title>Peritoneal cell-derived mast cells: an in&#x000a0;vitro model of mature serosal-type mouse mast cells</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><fpage>6465</fpage><lpage>6475</lpage></citation><citation citation-type="display-unstructured">Malbec O, Roget K, Schiffer C, Iannascoli B, Dumas AR, Arock M, Da&#x000eb;ron M (2007) Peritoneal cell-derived mast cells: an in&#x000a0;vitro model of mature serosal-type mouse mast cells. J Immunol 178:6465&#x02013;6475 <pub-id pub-id-type="pmid">17475876</pub-id></citation></ref><ref id="CR16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>JS</given-names></name><name><surname>Jawdat</surname><given-names>DM</given-names></name></person-group><article-title>Mast cells in innate immunity</article-title><source>J Allergy Clin Immunol</source><year>2004</year><volume>114</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2004.04.045</pub-id></citation><citation citation-type="display-unstructured">Marshall JS, Jawdat DM (2004) Mast cells in innate immunity. J Allergy Clin Immunol 114:21&#x02013;27 <pub-id pub-id-type="pmid">15241339</pub-id></citation></ref><ref id="CR17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metcalfe</surname><given-names>DD</given-names></name><name><surname>Baram</surname><given-names>D</given-names></name><name><surname>Mekori</surname><given-names>YA</given-names></name></person-group><article-title>Mast cells</article-title><source>Physiol Rev</source><year>1997</year><volume>77</volume><fpage>1033</fpage><lpage>1079</lpage></citation><citation citation-type="display-unstructured">Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77:1033&#x02013;1079 <pub-id pub-id-type="pmid">9354811</pub-id></citation></ref><ref id="CR18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Sonoda</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>C</given-names></name><name><surname>Amatodani</surname><given-names>A</given-names></name><name><surname>Kanayama</surname><given-names>Y</given-names></name><name><surname>Yamamura</surname><given-names>T</given-names></name><name><surname>Asai</surname><given-names>H</given-names></name><name><surname>Yonezawa</surname><given-names>T</given-names></name><name><surname>Kitamura</surname><given-names>Y</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name></person-group><article-title>Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells</article-title><source>J Exp Med</source><year>1985</year><volume>162</volume><fpage>1025</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1084/jem.162.3.1025</pub-id></citation><citation citation-type="display-unstructured">Nakano T, Sonoda T, Hayashi C, Amatodani A, Kanayama Y, Yamamura T, Asai H, Yonezawa T, Kitamura Y, Galli SJ (1985) Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 162:1025&#x02013;1043 <pub-id pub-id-type="pmid">3897446</pub-id></citation></ref><ref id="CR19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osoegawa</surname><given-names>K</given-names></name><name><surname>Tateno</surname><given-names>M</given-names></name><name><surname>Woon</surname><given-names>PY</given-names></name><name><surname>Frengen</surname><given-names>E</given-names></name><name><surname>Mammoser</surname><given-names>AG</given-names></name><name><surname>Catanese</surname><given-names>JJ</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Jong</surname><given-names>PJ</given-names></name></person-group><article-title>Bacterial artificial chromosome libraries for mouse sequencing and functional analysis</article-title><source>Genome Res</source><year>2000</year><volume>10</volume><fpage>116</fpage><lpage>128</lpage></citation><citation citation-type="display-unstructured">Osoegawa K, Tateno M, Woon PY, Frengen E, Mammoser AG, Catanese JJ, Hayashizaki Y, de Jong PJ (2000) Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. Genome Res 10:116&#x02013;128 <pub-id pub-id-type="pmid">10645956</pub-id></citation></ref><ref id="CR20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Kuhn</surname><given-names>R</given-names></name><name><surname>Betz</surname><given-names>UA</given-names></name><name><surname>Muller</surname><given-names>W</given-names></name><name><surname>Roes</surname><given-names>J</given-names></name><name><surname>Schwenk</surname><given-names>F</given-names></name></person-group><article-title>Conditional gene targeting</article-title><source>J Clin Invest</source><year>1996</year><volume>98</volume><fpage>600</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1172/JCI118828</pub-id></citation><citation citation-type="display-unstructured">Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, Roes J, Schwenk F (1996) Conditional gene targeting. J Clin Invest 98:600&#x02013;603 <pub-id pub-id-type="pmid">8698848</pub-id></citation></ref><ref id="CR21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt-Supprian</surname><given-names>M</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><article-title>Vagaries of conditional gene targeting</article-title><source>Nat Immunol</source><year>2007</year><volume>8</volume><fpage>665</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1038/ni0707-665</pub-id></citation><citation citation-type="display-unstructured">Schmidt-Supprian M, Rajewsky K (2007) Vagaries of conditional gene targeting. Nat Immunol 8:665&#x02013;668 <pub-id pub-id-type="pmid">17579640</pub-id></citation></ref><ref id="CR22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Secor</surname><given-names>VH</given-names></name><name><surname>Secor</surname><given-names>WE</given-names></name><name><surname>Gutekunst</surname><given-names>CA</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name></person-group><article-title>Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis</article-title><source>J Exp Med</source><year>2000</year><volume>191</volume><fpage>813</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1084/jem.191.5.813</pub-id></citation><citation citation-type="display-unstructured">Secor VH, Secor WE, Gutekunst CA, Brown MA (2000) Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191:813&#x02013;822 <pub-id pub-id-type="pmid">10704463</pub-id></citation></ref><ref id="CR23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimshek</surname><given-names>DR</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>H&#x000fc;bner</surname><given-names>MR</given-names></name><name><surname>Spergel</surname><given-names>DJ</given-names></name><name><surname>Buchholz</surname><given-names>F</given-names></name><name><surname>Casanova</surname><given-names>E</given-names></name><name><surname>Stewart</surname><given-names>AF</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name></person-group><article-title>Codon-improved Cre recombinase (iCre) expression in the mouse</article-title><source>Genesis</source><year>2002</year><volume>32</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1002/gene.10023</pub-id></citation><citation citation-type="display-unstructured">Shimshek DR, Kim J, H&#x000fc;bner MR, Spergel DJ, Buchholz F, Casanova E, Stewart AF, Seeburg PH, Sprengel R (2002) Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis 32:19&#x02013;26 <pub-id pub-id-type="pmid">11835670</pub-id></citation></ref><ref id="CR24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sparwasser</surname><given-names>T</given-names></name><name><surname>Gong</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>JY</given-names></name><name><surname>Eberl</surname><given-names>G</given-names></name></person-group><article-title>General method for the modification of different BAC types and the rapid generation of BAC transgenic mice</article-title><source>Genesis</source><year>2004</year><volume>38</volume><fpage>39</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1002/gene.10249</pub-id></citation><citation citation-type="display-unstructured">Sparwasser T, Gong S, Li JY, Eberl G (2004) General method for the modification of different BAC types and the rapid generation of BAC transgenic mice. Genesis 38:39&#x02013;50 <pub-id pub-id-type="pmid">14755803</pub-id></citation></ref><ref id="CR25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srinivas</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>CS</given-names></name><name><surname>William</surname><given-names>CM</given-names></name><name><surname>Tanabe</surname><given-names>Y</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name><name><surname>Costantini</surname><given-names>F</given-names></name></person-group><article-title>Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus</article-title><source>BMC Dev Biol</source><year>2001</year><volume>1</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1186/1471-213X-1-4</pub-id></citation><citation citation-type="display-unstructured">Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, Costantini F (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1:4 <pub-id pub-id-type="pmid">11299042</pub-id></citation></ref><ref id="CR26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Sukhova</surname><given-names>GK</given-names></name><name><surname>Wolters</surname><given-names>PJ</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Kitamoto</surname><given-names>S</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Macfarlane</surname><given-names>LA</given-names></name><name><surname>Clair</surname><given-names>JM</given-names></name><name><surname>Shi</surname><given-names>GP</given-names></name></person-group><article-title>Mast cells promote atherosclerosis by releasing proinflammatory cytokines</article-title><source>Nat Med</source><year>2007</year><volume>13</volume><fpage>719</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1038/nm1601</pub-id></citation><citation citation-type="display-unstructured">Sun J, Sukhova GK, Wolters PJ, Yang M, Kitamoto S, Libby P, Macfarlane LA, Clair JM, Shi GP (2007) Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13:719&#x02013;724 <pub-id pub-id-type="pmid">17546038</pub-id></citation></ref><ref id="CR27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trautmann</surname><given-names>A</given-names></name><name><surname>Toksoy</surname><given-names>A</given-names></name><name><surname>Engelhardt</surname><given-names>E</given-names></name><name><surname>Brocker</surname><given-names>EB</given-names></name><name><surname>Gillitzer</surname><given-names>R</given-names></name></person-group><article-title>Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in&#x000a0;vivo</article-title><source>J Pathol</source><year>2000</year><volume>190</volume><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9896(200001)190:1&#x0003c;100::AID-PATH496&#x0003e;3.0.CO;2-Q</pub-id></citation><citation citation-type="display-unstructured">Trautmann A, Toksoy A, Engelhardt E, Brocker EB, Gillitzer R (2000) Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in&#x000a0;vivo. J Pathol 190:100&#x02013;106 <pub-id pub-id-type="pmid">10640999</pub-id></citation></ref><ref id="CR28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>M</given-names></name><name><surname>Grimbaldeston</surname><given-names>MA</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Tam</surname><given-names>SY</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name></person-group><article-title>Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in&#x000a0;vivo</article-title><source>Chem Immunol Allergy</source><year>2005</year><volume>87</volume><fpage>179</fpage><lpage>197</lpage></citation><citation citation-type="display-unstructured">Tsai M, Grimbaldeston MA, Yu M, Tam SY, Galli SJ (2005) Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in&#x000a0;vivo. Chem Immunol Allergy 87:179&#x02013;197 <pub-id pub-id-type="pmid">16107772</pub-id></citation></ref><ref id="CR29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>M</given-names></name><name><surname>Tam</surname><given-names>SY</given-names></name><name><surname>Wedemeyer</surname><given-names>J</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name></person-group><article-title>Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in&#x000a0;vitro and in&#x000a0;vivo</article-title><source>Int J Hematol</source><year>2002</year><volume>75</volume><fpage>345</fpage><lpage>349</lpage></citation><citation citation-type="display-unstructured">Tsai M, Tam SY, Wedemeyer J, Galli SJ (2002) Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in&#x000a0;vitro and in&#x000a0;vivo. Int J Hematol 75:345&#x02013;349 <pub-id pub-id-type="pmid">12041662</pub-id></citation></ref><ref id="CR30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>M</given-names></name><name><surname>Wedemeyer</surname><given-names>J</given-names></name><name><surname>Ganiatsas</surname><given-names>S</given-names></name><name><surname>Tam</surname><given-names>SY</given-names></name><name><surname>Zon</surname><given-names>LI</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name></person-group><article-title>In&#x000a0;vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in&#x000a0;vivo</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><fpage>9186</fpage><lpage>9190</lpage><pub-id pub-id-type="doi">10.1073/pnas.160254997</pub-id></citation><citation citation-type="display-unstructured">Tsai M, Wedemeyer J, Ganiatsas S, Tam SY, Zon LI, Galli SJ (2000) In&#x000a0;vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in&#x000a0;vivo. Proc Natl Acad Sci U S A 97:9186&#x02013;9190 <pub-id pub-id-type="pmid">10908668</pub-id></citation></ref><ref id="CR31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weller</surname><given-names>K</given-names></name><name><surname>Foitzik</surname><given-names>K</given-names></name><name><surname>Paus</surname><given-names>R</given-names></name><name><surname>Syska</surname><given-names>W</given-names></name><name><surname>Maurer</surname><given-names>M</given-names></name></person-group><article-title>Mast cells are required for normal healing of skin wounds in mice</article-title><source>FASEB J</source><year>2006</year><volume>20</volume><fpage>2366</fpage><lpage>2368</lpage><pub-id pub-id-type="doi">10.1096/fj.06-5837fje</pub-id></citation><citation citation-type="display-unstructured">Weller K, Foitzik K, Paus R, Syska W, Maurer M (2006) Mast cells are required for normal healing of skin wounds in mice. FASEB J 20:2366&#x02013;2368 <pub-id pub-id-type="pmid">16966487</pub-id></citation></ref><ref id="CR32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Buchholz</surname><given-names>F</given-names></name><name><surname>Muyrers</surname><given-names>JPP</given-names></name><name><surname>Stewart</surname><given-names>AF</given-names></name></person-group><article-title>A new logic for DNA engineering using recombination in Escherichia coli</article-title><source>Nat Genet</source><year>1998</year><volume>20</volume><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1038/2417</pub-id></citation><citation citation-type="display-unstructured">Zhang Y, Buchholz F, Muyrers JPP, Stewart AF. (1998) A new logic for DNA engineering using recombination in Escherichia coli Nat Genet 20:123&#x02013;128 <pub-id pub-id-type="pmid">9771703</pub-id></citation></ref></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>BAC</term><def><p>Bacterial artificial chromosome</p></def></def-item><def-item><term>BMMC</term><def><p>Bone marrow-derived mast cells</p></def></def-item><def-item><term>EYFP</term><def><p>Enhanced yellow fluorescent protein</p></def></def-item><def-item><term>FACS</term><def><p>Fluorescence activated cell sorting</p></def></def-item><def-item><term>floxed</term><def><p><italic>loxP</italic>-flanked</p></def></def-item><def-item><term>kb</term><def><p>Kilobases</p></def></def-item><def-item><term>Mcpt</term><def><p>Mast cell protease</p></def></def-item><def-item><term>HR</term><def><p>Homology region</p></def></def-item><def-item><term>MACS</term><def><p>Magnetic activated cell sorting</p></def></def-item><def-item><term>neo</term><def><p>Neomycin resistance gene</p></def></def-item><def-item><term>SCF</term><def><p>Stem cell factor</p></def></def-item></def-list></glossary><fn-group><fn><p>Julia Scholten and Karin Hartmann contributed equally to this work. </p><p>Supported by grants from the German Research Counsil (Deutsche Forschungsgemeinschaft, RO 2133/2-2) to A.R. and K.H. and the Koeln Fortune Program/Faculty of Medicine, University of Cologne, to A.R. and K.H.. The authors have no conflict of interest</p></fn></fn-group></back></article> 